According to the recent study the stent market is projected to reach an estimated $24 billion by 2030 from $17 billion in 2023 at a CAGR of 5.2% from 2023 to 2030. Growth in this market is primarily driven by increasing interventional cardiology and peripheral vascular procedures and rising adoption of technological advancements in an effort to reduce treatment duration for high risk conventional surgical patients.
Browse 83 figures/charts
and 74 tables in this 181-page report to understand trends, opportunities and
forecast in stent market by product type (coronary stent and peripheral
vascular stent), material (metal and polymer), technology (bare metal stent,
drug eluting stent, and bioreabsorbable stent), end use (hospital and
ambulatory surgical center), and region (North America, Europe, Asia Pacific,
and the Rest of the World).
“Coronary stent market is expected to remain the largest segment
during the forecast period.”
Based on product type,
the stent market is segmented into coronary stent and peripheral vascular
stent. Lucintel forecasts that the coronary stent market is expected to remain
the largest segment due to increasing cases of cardiovascular disorders.
“Within the stent market, the drug eluting stents segment is
expected to remain the largest technology.”
Based on technology the
drug eluting stents segment is expected to witness the highest growth over the
forecast period due to low restenosis rate after surgery.
“North America will dominate the stent market in near future.”
North America is
expected to remain the largest market during the forecast period mainly due to
its well-developed healthcare infrastructure and continued technological
advancements across the healthcare industry.
Major players of stent
market are adopting various growth strategies like new product launches,
expansions, merger and acquisitions, partnerships, agreements, and
collaborations to expand their presence in this market. Abbott Laboratory,
Boston Scientific, Medtronic public limited company, C R Bard, Cook Medical
Inc., Terumo Corporation, and Cardinal Health are among the major stent
providers.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Explore Our Latest Publications
Paternity & Relationship Testing Services Market
No comments:
Post a Comment